GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » Additional Paid-In Capital

BioTech Medics (BioTech Medics) Additional Paid-In Capital : $0.00 Mil(As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTech Medics Additional Paid-In Capital?



BioTech Medics Additional Paid-In Capital Historical Data

The historical data trend for BioTech Medics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics Additional Paid-In Capital Chart

BioTech Medics Annual Data
Trend
Additional Paid-In Capital

BioTech Medics Quarterly Data
Additional Paid-In Capital

BioTech Medics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

BioTech Medics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioTech Medics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTech Medics (BioTech Medics) Business Description

Traded in Other Exchanges
N/A
Address
5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.